Atypical Breast Proliferative Lesions and Benign Breast Disease

The days of surgical excision for any atypical lesion have been replaced by more nuanced decision making and individualized patient management. Current management of many of these lesions continues to be controversial in regard to observation with close surveillance versus the need for surgical exci...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Amersi, Farin (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Calhoun, Kristine (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2018.
Έκδοση:1st ed. 2018.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04734nam a2200517 4500
001 978-3-319-92657-5
003 DE-He213
005 20190620141022.0
007 cr nn 008mamaa
008 180927s2018 gw | s |||| 0|eng d
020 |a 9783319926575  |9 978-3-319-92657-5 
024 7 |a 10.1007/978-3-319-92657-5  |2 doi 
040 |d GrThAP 
050 4 |a RD1-811 
072 7 |a MNC  |2 bicssc 
072 7 |a MED085000  |2 bisacsh 
072 7 |a MNC  |2 thema 
082 0 4 |a 617  |2 23 
245 1 0 |a Atypical Breast Proliferative Lesions and Benign Breast Disease   |h [electronic resource] /  |c edited by Farin Amersi, Kristine Calhoun. 
250 |a 1st ed. 2018. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2018. 
300 |a XI, 197 p. 28 illus., 24 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a The Spectrum of Risk Lesions in Breast Pathology: Risk Factors or Cancer Precursors? -- Lobular Carcinoma In Situ: Risk Factor or Cancer Precursor? -- Ductal Carcinoma In Situ: Risk Factor or Cancer -- Diagnostic Management of Papillomas, Radial Scars, and Flat Epithelial Atypia: Core Biopsy Alone Versus Core Biopsy Plus Excision -- Diagnostic Management of Fibroepithelial Lesions: When Is Excision Indicated? -- Diagnostic Management of the Atypical Hyperplasias: Core Biopsy Alone vs Excisional Biopsy -- Diagnostic management of LCIS: Core biopsy alone versus core biopsy plus excision for classic versus pleomorphic LCIS -- Breast Cancer Risk Prediction in Women with Atypical Breast Lesions -- Advanced Screening Options and Surveillance in Women with Atypical Breast Lesions -- The Role of Chemoprevention in the Prevention of Breast Cancer -- Prophylactic Mastectomy in Patients with Atypical Breast Lesions -- The Non-surgical Management of Ductal Carcinoma in Situ (DCIS) -- Surgical Treatment of Ductal Carcinoma in Situ. . 
520 |a The days of surgical excision for any atypical lesion have been replaced by more nuanced decision making and individualized patient management. Current management of many of these lesions continues to be controversial in regard to observation with close surveillance versus the need for surgical excision of these lesions based on future risk or whether these lesions are precursor lesion. The goal of this book is to provide a concise but comprehensive review of atypical breast proliferative lesions and their management complexities. New data about breast cancer, risk factors for breast cancer, pathological features unique to each entity, the characteristic findings on imaging, risk stratification for genetic testing, as well as the current evidence-based management of each of these breast lesions are discussed in full detail. Assessment tools for risk prediction of breast cancer are also highlighted as chapters run the gamut of current imaging modalities, as well as advanced screening options available for diagnosis and following these patients. Atypical Breast Proliferative Lesions and Benign Breast Disease will undoubtedly become a valuable resource for nurse practitioners, physician assistants, breast and surgical oncology fellows, genetic counselors, geneticists, as well as other clinicians and surgeons who are referred and manage these complex breast patients. All chapters in this text are written by experts in the field who have research and clinical interest in each of these disease entities, and include the most up-to-date research and clinical information to enhance our understanding and treatment of patients. 
650 0 |a Surgery. 
650 0 |a Surgical oncology. 
650 0 |a Oncology  . 
650 0 |a Pathology. 
650 1 4 |a General Surgery.  |0 http://scigraph.springernature.com/things/product-market-codes/H59044 
650 2 4 |a Surgical Oncology.  |0 http://scigraph.springernature.com/things/product-market-codes/H59150 
650 2 4 |a Oncology.  |0 http://scigraph.springernature.com/things/product-market-codes/H33160 
650 2 4 |a Pathology.  |0 http://scigraph.springernature.com/things/product-market-codes/H4800X 
700 1 |a Amersi, Farin.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Calhoun, Kristine.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319926568 
776 0 8 |i Printed edition:  |z 9783319926582 
776 0 8 |i Printed edition:  |z 9783030064822 
856 4 0 |u https://doi.org/10.1007/978-3-319-92657-5  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)